Citation: F. Scheiflinger et al., TRANSIENT MARKER STABILIZATION - A GENERAL PROCEDURE TO CONSTRUCT MARKER-FREE RECOMBINANT VACCINIA VIRUS, Archives of virology, 143(3), 1998, pp. 467-474
Authors:
HERLITSCHKA SE
SCHLOKAT U
FALKNER FG
DORNER F
Citation: Se. Herlitschka et al., HIGH EXPRESSION OF A B-DOMAIN DELETED FACTOR-VIII GENE IN A HUMAN HEPATIC CELL-LINE, Journal of biotechnology, 61(3), 1998, pp. 165-173
Authors:
HOLZER GW
GRITSCHENBERGER W
MAYRHOFER JA
WIESER V
DORNER F
FALKNER FG
Citation: Gw. Holzer et al., DOMINANT HOST-RANGE SELECTION OF VACCINIA RECOMBINANTS BY RESCUE OF AN ESSENTIAL GENE, Virology (New York, N.Y. Print), 249(1), 1998, pp. 160-166
Authors:
ANTOINE G
SCHEIFLINGER F
DORNER F
FALKNER FG
Citation: G. Antoine et al., THE COMPLETE GENOMIC SEQUENCE OF THE MODIFIED VACCINIA ANKARA STRAIN - COMPARISON WITH OTHER ORTHOPOXVIRUSES, Virology, 244(2), 1998, pp. 365-396
Authors:
KIM WK
TANG Y
OKADA Y
TORREY TA
CHATTOPADHYAY SK
PFLEIDERER M
FALKNER FG
DORNER F
CHOI W
HIROKAWA N
MORSE HC
Citation: Wk. Kim et al., BINDING OF MURINE LEUKEMIA-VIRUS GAG POLYPROTEINS TO KIF4, A MICROTUBULE-BASED MOTOR PROTEIN, Journal of virology, 72(8), 1998, pp. 6898-6901
Authors:
HAMMERLE T
HIMMELSPACH M
DORNER F
FALKNER FG
Citation: T. Hammerle et al., A SENSITIVE PCR ASSAY SYSTEM FOR THE QUANTITATION OF VIRAL GENOME EQUIVALENTS - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HEPATITIS-BVIRUS (HBV), Archives of virology, 142(7), 1997, pp. 1297-1306
Citation: F. Scheiflinger et al., ROLE OF THE FOWLPOX VIRUS THYMIDINE KINASE GENE FOR THE GROWTH OF FPVRECOMBINANTS IN CELL-CULTURE, Archives of virology, 142(12), 1997, pp. 2421-2431
Citation: Gw. Holzer et Fg. Falkner, CONSTRUCTION OF A VACCINIA VIRUS DEFICIENT IN THE ESSENTIAL DNA-REPAIR ENZYME URACIL DNA GLYCOSYLASE BY A COMPLEMENTING CELL-LINE, Journal of virology, 71(7), 1997, pp. 4997-5002
Authors:
HERLITSCHKA SE
FALKNER FG
SCHLOKAT U
DORNER F
Citation: Se. Herlitschka et al., OVEREXPRESSION OF HUMAN PROTHROMBIN IN PERMANENT CELL-LINES USING A DOMINANT SELECTION AMPLIFICATION FUSION MARKER, Protein expression and purification, 8(3), 1996, pp. 358-364
Authors:
SCHLOKAT U
FISCHER BE
HERLITSCHKA S
ANTOINE G
PREININGER A
MOHR G
HIMMELSPACH M
KISTNER O
FALKNER FG
DORNER F
Citation: U. Schlokat et al., PRODUCTION OF HIGHLY HOMOGENEOUS AND STRUCTURALLY INTACT RECOMBINANT VON-WILLEBRAND-FACTOR MULTIMERS BY FURIN-MEDIATED PROPEPTIDE REMOVAL IN-VITRO, Biotechnology and applied biochemistry, 24, 1996, pp. 257-267
Authors:
ANTOINE G
SCHEIFLINGER F
HOLZER G
LANGMANN T
FALKNER FG
DORNER F
Citation: G. Antoine et al., CHARACTERIZATION OF THE VACCINIA MVA HEMAGGLUTININ GENE LOCUS AND ITSEVALUATION AS AN INSERTION SITE FOR FOREIGN GENES, Gene, 177(1-2), 1996, pp. 43-46
Citation: M. Pfleiderer et al., DELETION OF THE MYRISTYLATION SIGNAL ALLOWS HIGH-LEVEL PRODUCTION OF THE HEPATITIS-B VIRUS LARGE SURFACE GLYCOPROTEIN PRES1 WITH VACCINIA VIRUS RECOMBINANTS, Gene, 176(1-2), 1996, pp. 131-137
Citation: F. Scheiflinger et al., EVALUATION OF THE THYMIDINE KINASE (TK) LOCUS AS AN INSERTION SITE INTHE HIGHLY ATTENUATED VACCINIA MVA STRAIN, Archives of virology, 141(3-4), 1996, pp. 663-669
Citation: T. Hammerle et al., A SENSITIVE PCR ASSAY SYSTEM FOR THE QUANTITATION OF VIRAL GENOME EQUIVALENTS - HEPATITIS-C VIRUS (HCV), Archives of virology, 141(11), 1996, pp. 2103-2114
Authors:
HIMMELSPACH M
GRUBER F
ANTOINE G
FALKNER FG
DORNER F
HAMMERLE T
Citation: M. Himmelspach et al., SPECIFIC QUANTITATION OF GENOMIC DNA IN THE FEMTOGRAM RANGE BY AMPLIFICATION OF REPETITIVE SEQUENCES, Analytical biochemistry, 242(2), 1996, pp. 240-247
Citation: M. Pfleiderer et al., REQUIREMENTS FOR OPTIMAL EXPRESSION OF SECRETED AND NONSECRETED RECOMBINANT PROTEINS IN VACCINIA VIRUS SYSTEMS, Protein expression and purification, 6(5), 1995, pp. 559-569
Authors:
HAMMERLE T
HIMMELSPACH M
FALKNER FG
ZERLAUTH G
IGEL H
BARRETT N
DORNER F
Citation: T. Hammerle et al., NEW ADDITIONAL RELEASE CRITERIA FOR BLOOD PRODUCTS DERIVED FROM POOLED HUMAN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1023-1023
Authors:
SIEKMANN J
TURECEK PL
FISCHER BE
MITTERER A
SCHLOKAT U
FALKNER FG
DORNER F
SCHWARZ HP
Citation: J. Siekmann et al., CHARACTERIZATION OF PLASMA-DERIVED AND RECOMBINANT HUMAN VWF BY IMPROVED COLLAGEN-BINDING ASSAYS, Thrombosis and haemostasis, 73(6), 1995, pp. 1160-1160
Authors:
FISCHER BE
TURECEL PL
MITTERER A
SCHLOKAT U
FALKNER FG
SCHWARZ HP
DORNER F
Citation: Be. Fischer et al., MULTIMERIC COMPOSITION AND STRUCTURAL-ANALYSIS OF A RECOMBINANT VON-WILLEBRAND-FACTOR (RVWF), Thrombosis and haemostasis, 73(6), 1995, pp. 1166-1166
Authors:
PFLEIDERER M
FALKNER FG
MUNDT W
FISCHER B
MITTERER A
DORNER F
Citation: M. Pfleiderer et al., EXPRESSION OF HUMAN PROTEIN-S WITH A NOVEL VACCINIA VIRUS SYSTEM - PURIFICATION AND FUNCTIONAL-ANALYSIS OF THE RECOMBINANT PRODUCT, Thrombosis and haemostasis, 73(6), 1995, pp. 1258-1258
Citation: M. Pfleiderer et al., A NOVEL VACCINIA VIRUS EXPRESSION SYSTEM ALLOWING CONSTRUCTION OF RECOMBINANTS WITHOUT THE NEED FOR SELECTION MARKERS, PLASMIDS AND BACTERIAL HOSTS, Journal of General Virology, 76, 1995, pp. 2957-2962
Authors:
DROUET L
ROUSSI J
BONNEAU M
PIGNAUD GA
TURECEK PL
DORNER F
SCHLOKAT U
FALKNER FG
FISCHER B
MITTERER A
SCHWARZ HP
Citation: L. Drouet et al., THE EFFECT OF RECOMBINANT HUMAN VON-WILLEBRAND-FACTOR IN PIGS WITH SEVERE VON WILLEBRANDS DISEASE, Blood, 86(10), 1995, pp. 2435-2435